Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Anim Physiol Anim Nutr (Berl) ; 97(2): 238-44, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22129393

RESUMO

The energetic status of high-yielding Holstein-Friesian dairy cattle was studied during peripartum under field conditions using body condition score (BCS), glycemia, seric ß-hydroxybutyrate and adipose tissue cellularity. This last method was tested as a complementary tool for energetic status assessment. Biopsies of pericaudal subcutaneous adipose tissue were obtained from 25 multiparous animals at 28 days before and 21 days after parturition. Samples were routinely processed for histological examination and stained with haematoxylin and eosin (H&E). The mean diameter of adipocytes (MDA) was measured with the aid of a digital image processor. During the same period, blood samples were collected weekly for metabolite determinations. The MDA at 28 days pre-partum and 21 days post-partum were 72.1 vs. 66.2 µm respectively (p = 0.055), and the corresponding BCS at these moments was 3.32 vs. 3.19 (p = 0.068). At -28 days pre-partum, the BCS was positively correlated with MDA (Pearson's r = 0.521, p = 0.016) and with glycemia (Pearson's r = 0.404, p = 0.056). Correlations between BCS and MDA, and between BCS and glycemia, with ß-hydroxybutyrate although not significant, suggest that routine histological preparations of biopsies from subcutaneous adipose tissue could be included as an easy and valuable tool for research purposes to evaluate metabolic adaptation of dairy cows to peripartum, as well as the incidence of metabolic disorders and productive performance.


Assuntos
Adipócitos/citologia , Bovinos/fisiologia , Período Periparto/fisiologia , Adipócitos/fisiologia , Animais , Composição Corporal , Bovinos/sangue , Metabolismo Energético , Feminino , Malondialdeído , Gravidez
2.
Sci Rep ; 11(1): 7132, 2021 03 30.
Artigo em Inglês | MEDLINE | ID: mdl-33785846

RESUMO

The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediately treated with a single dose of 500 µg/kg ivermectin (group infected + IVM, n = 20) or were not infected and treated with PBS (control group, n = 16). Five days after infection/treatment, the mice were euthanized and the tissues were sampled to assess their general health status and infection levels. Overall, the results demonstrated that viral infection induced typical MHV-caused disease, with the livers showing severe hepatocellular necrosis surrounded by a severe lymphoplasmacytic inflammatory infiltration associated with a high hepatic viral load (52,158 AU), while mice treated with ivermectin showed a better health status with a lower viral load (23,192 AU; p < 0.05), with only a few having histopathological liver damage (p < 0.05). No significant differences were found between the group infected + IVM and control group mice (P = NS). Furthermore, serum transaminase levels (aspartate aminotransferase and alanine aminotransferase) were significantly lower in the treated mice than in the infected animals. In conclusion, ivermectin diminished the MHV viral load and disease in the mice, being a useful model for further understanding this therapy against coronavirus diseases.


Assuntos
Antivirais/farmacologia , Infecções por Coronavirus/tratamento farmacológico , Ivermectina/farmacologia , Animais , Antivirais/administração & dosagem , Peso Corporal/efeitos dos fármacos , Infecções por Coronavirus/patologia , Infecções por Coronavirus/virologia , Modelos Animais de Doenças , Feminino , Ivermectina/administração & dosagem , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Fígado/virologia , Camundongos Endogâmicos BALB C , Monócitos/efeitos dos fármacos , Vírus da Hepatite Murina/patogenicidade , Neutrófilos/efeitos dos fármacos , Proteínas/metabolismo , Transaminases/metabolismo , Fator de Necrose Tumoral alfa/sangue , Carga Viral/efeitos dos fármacos
3.
Vet Pathol ; 47(3): 569-72, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20234028

RESUMO

Solanum bonariense intoxication is characterized by cerebellar neuronal vacuolation, degeneration, and necrosis. Cerebellar Purkinje cells seem especially susceptible, but more research is needed to determine the pathogenesis of neuronal necrosis and the mechanism of Purkinje cell susceptibility. Calbindin D28k (CbD28k) is highly expressed in Purkinje cells and has been used as a marker for normal and degenerative Purkinje cells. The goal of this study was to describe S bonariense-induced disease by ascertaining Purkinje cell-specific degenerative changes using CbD28k expression and to correlate this with apoptosis in Purkinje cells, as determined using TUNEL (transferase-mediated dUTP-biotin nick end-labeling) and ultrastructural changes. In all cases, an increase in both dose and duration of S bonariense intoxication resulted in a decrease in the number of Purkinje cells. CbD28k immunohistochemistry was an excellent marker for Purkinje cells because immunoreactivity did not change in normal or degenerative tissues. This finding suggests that excessive calcium excitatory stimulation does not induce rapid neuronal degeneration and death. As found in previous studies, TUNEL tests and electron microscopy suggest that Purkinje cell degeneration and death are not occurring via an apoptotic process. These findings suggest that S bonariense poisoning induces progressive Purkinje cell death that is not mediated by excitotoxicity or apoptotic activation.


Assuntos
Apoptose , Doenças dos Bovinos/metabolismo , Cerebelo/metabolismo , Intoxicação por Plantas/veterinária , Proteína G de Ligação ao Cálcio S100/metabolismo , Solanum/intoxicação , Animais , Calbindinas , Bovinos , Doenças dos Bovinos/patologia , Cerebelo/patologia , Feminino , Masculino , Intoxicação por Plantas/metabolismo , Intoxicação por Plantas/patologia , Células de Purkinje/metabolismo , Células de Purkinje/patologia , Alcaloides de Solanáceas/intoxicação
4.
J Neurol Sci ; 126(1): 1-5, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7530767

RESUMO

Dorsal root ganglion neurons from streptozotocin (STZ)-induced diabetic, genetic diabetic and normal mice were cultured in serum-containing media with or without nerve growth factor (NGF). The immunocytochemical analysis carried out after 1 week in culture revealed that the ratios of neurons immunoreactive to calcitonin gene-related peptide (CGRP) in NGF-free medium in the STZ-diabetic mice (average 23.2%) were significantly lower than those in the normal mice (45.1%). The ratios of neurons immunoreactive to CGRP and substance P (SP) in the NGF-free medium were also lower in the genetic diabetic mice (23.6% and 21.8%) than those in the normal ones (40.7% and 34.2%). However, treatment with NGF restored these reduced immunoreactivities in the diabetic groups in a dose-dependent manner. These results show that NGF can be effective for the diabetes-induced depletion of CGRP and SP in sensory neurons, and suggest its possible role in the prevention and improvement of diabetic sensory neuropathy.


Assuntos
Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Diabetes Mellitus Experimental/complicações , Neuropatias Diabéticas/patologia , Fatores de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso/metabolismo , Neurônios Aferentes/efeitos dos fármacos , Substância P/metabolismo , Animais , Peptídeo Relacionado com Gene de Calcitonina/deficiência , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/patologia , Feminino , Gânglios Espinais/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos NOD , Proteínas do Tecido Nervoso/deficiência , Neurônios Aferentes/metabolismo , Estreptozocina , Substância P/deficiência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA